Amphion Innovations (AMP)

 

AMP Share PerformanceMore

52 week high3.9500 26/04/17
52 week low0.8150 28/11/17
52 week change -2.8000 (-70.00%)
4 week volume6,331,591 31/03/18
price1.2000
price date1524669443
close1.2000

Latest NewsMore

Directorate Change

RNS Number: 5404L Amphion Innovations PLC 20 April 2018 Amphion Innovations plc ("Amphion" or "the Company") Directorate Change London and New York, 20 April 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that Miroslaw Izienicki and Richard Mansell-Jones have resigned as N...

AIM Admission & First Day of Dealings

RNS Number: 3251J Polarean Imaging PLC 29 March 2018 Polarean Imaging Plc ("Polarean", the "Company" or the "Group") Admission to trading on AIM and First Day of Dealings Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market,...

Update on Polarean Imaging IPO

RNS Number: 3254J Amphion Innovations PLC 29 March 2018 Amphion Innovations plc ("Amphion" or "the Company") Update on Polarean Imaging IPO London and New York, 29 March 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, notes that its partner companyPolarean Imaging plc ("Polarean") ...

Amphion Innovations participates in Polarean Imaging IPO

Amphion Innovations said it said it had participated in an initial public offering of Polarean Imaging and would remain i...

Update on Polarean Imaging proposed AIM IPO

RNS Number: 8405I Amphion Innovations PLC 26 March 2018 Amphion Innovations plc ("Amphion" or "the Company") Update on Polarean Imaging proposed AIM IPO London and New York, 26 March 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces a further update regarding its partner c...

Convertible promissory note extended to December

RNS Number: 4698G Amphion Innovations PLC 02 March 2018 AMPHION INNOVATIONS PLC ("Amphion" or "the Company") Convertible Promissory Note Extended to December 2018 London and New York, 2 March 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that on 26 February 2...

Director dealing

RNS Number: 5371B Amphion Innovations PLC 10 January 2018 AMPHION INNOVATIONS PLC ("Amphion" or "the Company") Directors' Dealings London and New York, 10 January 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that on 5 January 2018 it granted options over ordinary sh...

Amphion agrees loan restructuring

Amphion Innovations has agreed terms for re-structuring the loan payments and the draw-down of an additional US $1,55...

Latest discussion posts More

  • Re: Expensive drawdown facility

    What to do? Sell or avoid? Have been watching this, but any upside to Motif will simply mean AMP selling stake to pay the debt/bills? Will any Motif windfall be squandered? ...
    15-Jul-2016
    bobsson
  • Re: Expensive drawdown facility

    Agree wholeheartedly! Conflicted company officers are electing, against their fiduciary duty, to unecessarily bleed our company dry when cheaper funding could clearly be ...
    13-Jul-2016
    nodebt
  • Expensive drawdown facility

    This facility seems very expensive $750,000 borrowed today and $881,000 having to be repaid in less than 4 months time and some of it being used to pay back a previous ...
    13-Jul-2016
    northumbrian-piper

Users' HoldingsMore

Users who hold Amphion Innovations also hold..

Codes & Symbols

ISINGB00B0DJNP99
SymbolsAMP, LSE:AMP, AMP.L, AMP:LN, LON:AMP, XLON:AMP